Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Should there be a size limit for elective nephron-sparing surgery?

Kent G Krejci1, Bradley C Leibovich

  • 1Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Current Urology Reports
|January 23, 2003
PubMed
Summary

Nephron-sparing surgery (NSS) offers excellent results for kidney tumors. Elective NSS is now supported for localized solid renal masses under 4 cm, even with a healthy opposite kidney.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Complications after Radical Nephrectomy with Venous Tumor Thrombectomy and Various IVC Reconstruction Approaches: A Simplified Risk Calculator.

Urology·2026
Same author

Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

TFEC-rearranged renal cell carcinoma.

Human pathology·2026
Same author

Whole-proteome phage immunoprecipitation sequencing reveals germ cell tumor-specific immunosignature.

Nature communications·2026
Same author

Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency).

Mayo Clinic proceedings·2026
Same author

A Simplified Prediction Tool for Metastasis After Nephrectomy With Venous Tumor Thrombectomy for RCC.

Urology·2026

Area of Science:

  • Urology
  • Nephrology
  • Surgical Oncology

Background:

  • Nephron-sparing surgery (NSS) is crucial for patients with solid renal masses and compromised renal function.
  • Elective NSS is increasingly chosen by patients with normal contralateral kidneys due to positive outcomes.
  • Optimal selection criteria for elective NSS remain undefined.

Purpose of the Study:

  • To review the evolution and recent outcomes of NSS.
  • To discuss critical patient selection factors for elective NSS.
  • To define criteria for elective NSS in localized solid renal masses.

Main Methods:

  • Literature review of NSS developments and outcomes.
  • Analysis of patient selection criteria for elective NSS.
  • Discussion of clinical features relevant to elective NSS.

Related Experiment Videos

Main Results:

  • NSS demonstrates excellent results in managing solid renal masses.
  • Elective NSS is a viable option for patients with normal contralateral kidneys.
  • Current evidence supports elective NSS for localized solid renal masses < 4 cm.

Conclusions:

  • NSS is a standard procedure for renal masses threatening kidney function.
  • Elective NSS is supported for small, localized renal masses (< 4 cm).
  • Further definition of selection criteria for elective NSS is warranted.